Maravai Lifesciences Holdings annual gross margin
2023
2024
2025
Maravai Lifesciences Holdings Gross Margin Growth & History (MRVI)
Maravai Lifesciences Holdings's gross margin was 18.30% for fiscal 2025.
View full Maravai Lifesciences Holdings company overviewMaravai Lifesciences Holdings annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 18.30% | −23.49 pp |
| 2024 | 2024-12-31 | 41.79% | −6.73 pp |
| 2023 | 2023-12-31 | 48.52% | — |
Maravai Lifesciences Holdings quarterly gross margin
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 40.14% | +23.75 pp |
| Q1 2026 | 2026-03-31 | 51.19% | +34.70 pp |
| Q4 2025 | 2025-12-31 | 25.75% | −20.95 pp |
| Q3 2025 | 2025-09-30 | 13.58% | — |
| Q2 2025 | 2025-06-30 | 16.39% | — |
| Q1 2025 | 2025-03-31 | 16.49% | — |
| Q3 2024 | 2024-09-30 | 46.70% | — |
Maravai Lifesciences Holdings gross margin trends
Across the available reported history, Maravai Lifesciences Holdings's gross margin decreased from 41.79% to 18.30%, a change of −23.49 percentage points. The latest reported quarter, Q2 2026, shows 40.14%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maravai Lifesciences Holdings filings at SEC.gov ↗